We found that both CD36 and EPO mRNA expression was elevated in NAFLD patients and, interestingly, a significant positive correlation between the mRNA levels of these genes was observed in the entire study population (Figure 6E,F). Here, EPO is linked to metabolic dysfunction-associated steatotic liver disease.